Search results
Results from the WOW.Com Content Network
Medicaid beneficiaries in North Carolina will soon be able to get GLP-1 drugs like Wegovy, Saxenda and Zepbound covered. NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for ...
Sam Watts, executive administrator of the State Health Plan, listens as the plan’s board of trustees debate options for coverage of weight loss drugs during a meeting on Thursday, Jan. 25, 2024 ...
Of those, about 300,000 North Carolinians — largely those on a limited-benefit, family-planning Medicaid program — will be moved into full coverage on Dec. 1, the launch date announced in ...
In the United States, Medicaid is a government program that provides health insurance for adults and children with limited income and resources. The program is partially funded and primarily managed by state governments, which also have wide latitude in determining eligibility and benefits, but the federal government sets baseline standards for state Medicaid programs and provides a ...
As initially passed, the ACA was designed to provide universal health care in the U.S.: those with employer-sponsored health insurance would keep their plans, those with middle-income and lacking employer-sponsored health insurance could purchase subsidized insurance via newly established health insurance marketplaces, and those with low-income would be covered by the expansion of Medicaid.
With North Carolina’s new budget, Medicaid expansion is now written into the law. Take a look at key policies included in expansion and how to sign up for this insurance program.
In addition, dual-eligibles may choose a type of MA plan called a dual-eligible special needs plan (D-SNP), which is designed to target the needs of this population. For Medicaid benefits, beneficiaries generally enroll in their state's Medicaid FFS program or a Medicaid managed care plan administered by an MCO under contract with the state.
North Carolina State Health Plan staff recommended ending coverage of weight loss drugs Friday in order to rein in spending on a class of drugs called GLP-1s, which has put the plan’s finances ...